Creo Medical Group PLC (CREO)

Industry Medical Devices


This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

9.76p

Buy

10.25p

arrow-down-0.125p (-1.23%)

Prices updated at 12 Dec 2025, 14:30 GMT
| Prices minimum 15 mins delay
|
Prices in GBX

Creo Medical Group PLC is a medical device company focused on surgical endoscopy. It has developed an electrosurgical platform that delivers microwave and bipolar radiofrequency.

Income statement

20232024
4m4m
2m2m
-27m-29m
-672.50-720.00
-22m-29m
-23m-26m
Sales, General and administrative30m30m
Interest expenses200,000400,000
Provision for income taxes-3m-1m
Operating expenses29m31m
Income before taxes-26m-29m
Net income available to common shareholders-22m-29m
-0.07-0.08
Net interest income500,000-200,000
Advertising and promotion--
Net investment income, net--
Realised capital gains (losses), net--
Total benefits, claims and expenses--
Earnings per share (diluted)-0.07-0.08
Free cash flow per share-0.1099-0.0605
Book value/share0.1910.115
Debt equity ratio0.0869570.04717

Balance sheet

20232024
Current assets38m56m
Current liabilities10m21m
Total capital64m44m
Total debt8m4m
Total equity60m42m
Total non current liabilities--
Loans4m2m
Total assets77m65m
Total liabilities--
Cash and cash equivalents3m9m
Common stock361m412m

Cash flow

20232024
Cash at beginning of period13m3m
Cash dividends paid--
-23m-23m
Investments (gains) losses-18m15m
3m12m
Net income--
-22m-22m
-2m-400,000
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.